Literature DB >> 3945949

Metabolism of inhaled dihalomethanes in vivo: differentiation of kinetic constants for two independent pathways.

M L Gargas, H J Clewell, M E Andersen.   

Abstract

Dihalomethanes are metabolized by two major pathways: an oxidative, cytochrome P-450-mediated pathway that has been previously thought to yield only CO, and a glutathione (GSH)-dependent one that yields CO2. Both give 2 mol of halide ion. We studied the kinetic properties of the two pathways in vivo by exposing male rats to various inhaled concentrations of CH2Cl2,CH2F2, CH2FCl, CH2BrCl, and CH2Br2 and determining end-exposure carboxyhemoglobin (HbCO) and plasma bromide (where appropriate). Closed atmosphere gas uptake studies were employed for CH2F2, CH2FCl, CH2Cl2, and CH2BrCl metabolism. A physiologically based kinetic model was used to determine kinetic constants based on gas uptake or plasma bromide data and these constants were used to predict HbCO concentrations. Oxidation was high affinity, low capacity. The maximum metabolic rates for this pathway with CH2Br2, CH2BrCl, and CH2Cl2 were, respectively, 72, 54, and 47 mumol metabolized/kg/hr. CH2FCl did not undergo significant oxidative metabolism and appears more like CH3C1 than a dihalomethane in its metabolic reactivity. The GSH pathway was low affinity, but high capacity and could be described as a single first-order process at all accessible exposure concentrations. The rate constant for this first-order GSH-dependent pathway was related as CH2BrCl greater than CH2Cl2 congruent to CH2FCl greater than CH2Br2 greater than CH2F2. Presumably bromide is a preferred leaving group but steric hindrance in the initial reaction with GSH is important with CH2Br2. We also studied the effects of pyrazole (which inhibits microsomal oxidation) and 2,3-epoxypropanol (which depletes GSH) on dihalomethane metabolism. Pyrazole abolished CO production from CH2Br2, CH2BrCl, and CH2Cl2. GSH depletion did not change the yield of halide ion from the high-affinity pathway; it did increase the steady-state HbCO concentrations with CH2Cl2 and CH2ClBr, but not with CH2Br2. The putative formyl chloride (FC) intermediate from CH2Cl2 or CH2BrCl appears to have a longer life than the formyl bromide from CH2Br2 and a significant portion of the FC (congruent to 20-30%) may react with other cellular nucleophiles instead of spontaneously decomposing to CO. This portion of the oxidative pathway probably yields CO2.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3945949     DOI: 10.1016/0041-008x(86)90196-1

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  10 in total

1.  Calcium dynamics in cardiac myocytes as a target of dichloromethane cardiotoxicity.

Authors:  P Hoffmann; S P Müller; K Heinroth; E Büchner; D Richards; M Toraason
Journal:  Arch Toxicol       Date:  1996       Impact factor: 5.153

2.  Dichloromethane as an inhibitor of cytochrome c oxidase in different tissues of rats.

Authors:  A Lehnebach; C Kuhn; D Pankow
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

3.  Different carcinogenic process in cholangiocarcinoma cases epidemically developing among workers of a printing company in Japan.

Authors:  Yasunori Sato; Shoji Kubo; Shigekazu Takemura; Yasuhiko Sugawara; Shogo Tanaka; Masahiro Fujikawa; Akira Arimoto; Kenichi Harada; Motoko Sasaki; Yasuni Nakanuma
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

Review 4.  Insights from epidemiology into dichloromethane and cancer risk.

Authors:  Glinda S Cooper; Cheryl Siegel Scott; Ambuja S Bale
Journal:  Int J Environ Res Public Health       Date:  2011-08-18       Impact factor: 3.390

5.  Quantitative Property-Property Relationship for Screening-Level Prediction of Intrinsic Clearance of Volatile Organic Chemicals in Rats and Its Integration within PBPK Models to Predict Inhalation Pharmacokinetics in Humans.

Authors:  Thomas Peyret; Kannan Krishnan
Journal:  J Toxicol       Date:  2012-05-22

6.  PBPK modeling/Monte Carlo simulation of methylene chloride kinetic changes in mice in relation to age and acute, subchronic, and chronic inhalation exposure.

Authors:  R S Thomas; R S Yang; D G Morgan; M P Moorman; H R Kermani; R A Sloane; R W O'Connor; B Adkins; M L Gargas; M E Andersen
Journal:  Environ Health Perspect       Date:  1996-08       Impact factor: 9.031

7.  Physiologically based pharmacokinetics and cancer risk assessment.

Authors:  M E Andersen; K Krishnan
Journal:  Environ Health Perspect       Date:  1994-01       Impact factor: 9.031

Review 8.  Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment.

Authors:  D Krewski; J R Withey; L F Ku; M E Andersen
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

Review 9.  Human health effects of dichloromethane: key findings and scientific issues.

Authors:  Paul M Schlosser; Ambuja S Bale; Catherine F Gibbons; Amina Wilkins; Glinda S Cooper
Journal:  Environ Health Perspect       Date:  2014-10-17       Impact factor: 9.031

10.  Spontaneous Production of Glutathione-Conjugated Forms of 1,2-Dichloropropane: Comparative Study on Metabolic Activation Processes of Dihaloalkanes Associated with Occupational Cholangiocarcinoma.

Authors:  Yu Toyoda; Tappei Takada; Hiroshi Suzuki
Journal:  Oxid Med Cell Longev       Date:  2017-05-07       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.